Veterinary Medicines

MASTIBIOVAC Zawiesina do wstrzykiwań

Authorised
  • Streptococcus agalactiae, Inactivated
  • Streptococcus dysgalactiae, Inactivated
  • Streptococcus uberis, Inactivated
  • STREPTOCOCCUS PYOGENES
  • STAPHYLOCOCCUS AUREUS
  • Trueperella pyogenes, Inactivated
  • Escherichia coli, serotype O111, strain J5, Inactivated
  • Escherichia coli, strain BOV-10, Inactivated
  • Escherichia coli, serotype K99 (fimbrial adhesin F41), strain BOV-14, Inactivated
  • Escherichia coli, strain BOV-15, Inactivated
Download as PDF

Product identification

Medicine name:
MASTIBIOVAC Zawiesina do wstrzykiwań
Active substance:
  • Streptococcus agalactiae, Inactivated
  • Streptococcus dysgalactiae, Inactivated
  • Streptococcus uberis, Inactivated
  • STREPTOCOCCUS PYOGENES
  • STAPHYLOCOCCUS AUREUS
  • Trueperella pyogenes, Inactivated
  • Escherichia coli, serotype O111, strain J5, Inactivated
  • Escherichia coli, strain BOV-10, Inactivated
  • Escherichia coli, serotype K99 (fimbrial adhesin F41), strain BOV-14, Inactivated
  • Escherichia coli, strain BOV-15, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Streptococcus agalactiae, Inactivated
    1.00
    millilitre(s)
    /
    5.00
    millilitre(s)
  • Streptococcus dysgalactiae, Inactivated
    1.00
    millilitre(s)
    /
    5.00
    millilitre(s)
  • Streptococcus uberis, Inactivated
    1.00
    relative potency
    /
    5.00
    millilitre(s)
  • STREPTOCOCCUS PYOGENES
    1.00
    millilitre(s)
    /
    5.00
    millilitre(s)
  • STAPHYLOCOCCUS AUREUS
    1.00
    relative potency
    /
    5.00
    millilitre(s)
  • Trueperella pyogenes, Inactivated
    1.00
    relative potency
    /
    5.00
    millilitre(s)
  • Escherichia coli, serotype O111, strain J5, Inactivated
    1.00
    relative potency
    /
    5.00
    millilitre(s)
  • Escherichia coli, strain BOV-10, Inactivated
    1.00
    relative potency
    /
    5.00
    millilitre(s)
  • Escherichia coli, serotype K99 (fimbrial adhesin F41), strain BOV-14, Inactivated
    1.00
    relative potency
    /
    5.00
    millilitre(s)
  • Escherichia coli, strain BOV-15, Inactivated
    1.00
    relative potency
    /
    5.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Biowet Drwalew Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Drwalewskie Zaklady Przemyslu Bioweterynaryjnego S.A.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 2153
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."